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Introduction
Alzheimer's disease (AD) remains the most common form of dementia in which the vast majority of cases can be attributed to inheritance of the APOE4 allele [1] . Since the discovery of APOE's genetic linkage to AD in 1993 [2] no clear mechanism has emerged to explain apolipoprotein (apo) E's role in disease, however multiple hypotheses have been proposed such as impaired clearance of amyloid beta (AB), disruption in lipid metabolism and aberrant immune response [3] [4] [5] . More than a quarter of the US population carries an APOE4 allele, underscoring the urgency for uncovering a mechanism to explain APOE4's link to an increased risk of AD [6] . The genes that modify APOE dependent risk remain to be identified, making it exceedingly important to examine putative non-genetic risk factors. Age is the most significant risk factor, followed by a long list of putative non-genetic risk factors such as diet, stress, physical activity, co-morbidities, etc. It is incumbent upon us to determine how much weight each of these risk factors imparts and how many (and in what combination) are required to precipitate this disease. In this review we look at the evidence for how much influence age, diet and APOE genotype impart on AD risk, understanding that while this combination of risk factors alone does not represent the totality of sporadic AD, it may represent one endophenotype of
Background
The APOE gene is polymorphic encoding three major allelic variants designated APOE2, E3 and E4, with each encoding a protein isoform that differs by one or two amino acids. In terms of function, the most fundamental difference between these isoforms is their relative binding affinity to the low density lipoprotein receptor (LDLR) family of proteins. Compared to apoE3 (100%), apoE4 has the highest binding affinity (122%) and apoE2 (37%) the lowest [7] [8] and it's possible that these differences in binding affinity to the LDLR are true for other proteins (e.g. TREM2, complement Factor H, C1q) as well [9] [10] [11] . Additional factors can modify apoE's affinity for the LDLR family of proteins such as; heparin sulfate proteoglycans, apoE protein dimerization, competitive protein interactions (e.g. amyloid beta), and receptor mutations [12] . Post-translational modifications (e.g. glycosylation and palmitoylation) as well as lipid content of lipoproteins may influence apoE protein-protein interactions as well.
Moreover, apoE2 and E3 can form homodimers in vivo which reduces their binding affinity even further [12] [13] . These apoE isoform affinity differences have been hypothesized to explain the observed plasma cholesterol gradient (E4>E3>E2) in Western populations which purports that apoE4 is more efficient in uptake of plasma cholesterol resulting in intracellular biofeedback reductions in LDLR production and thus higher plasma cholesterol in APOE4 carriers [14] .
These affinity differences may also explain the gradient of apoE protein levels (E2>E3>E4) observed in the extracellular space (i.e. blood, cerebral spinal fluid) as apoE4 is internalized by receptor competent target cells more efficiently than E3 and E2 [15, 16] . Furthermore, these differences affect lipid homeostasis which illustrates why APOE4 carriers are at increased risk of diet induced atherosclerosis compared to APOE3 carriers [17] [18] [19] [7] .
In addition to maintaining lipid homeostasis, there is a large body of evidence supporting apoE's role in inflammation (covered in detail in this issue). In summary, multiple studies show that a gradient of immune/inflammatory response (E4>E3>E2) exists in response to J o u r n a l P r e -p r o o f injury/pathogens [20] [21] [22] [23] [24] [25] [26, 27] [28] . This may also explain why the APOE4 allele frequency remains high due to increased survival rates from infections in APOE4 carriers as only 100 years ago, infectious disease was the number one cause of death [29] [30] .
Evolution of APOE
Humans are the only species to contain more than one form of APOE and evolutionary studies demonstrate that APOE4 is the ancestral allele [31] [32] . All other animal species contain one form of apoE, resembling apoE4 in primary structure [12] but purportedly apoE3 in function [33] . A better understanding of apoE evolution may provide insight into present day apoE isoform specific risks linked to AD. The selective pressure for maintaining APOE4 allele frequency may be due to increased survival from infectious disease but this hypothesis fails to explain the selective pressures that resulted in the APOE3 and E2 variants. It has been postulated that the APOE3 variant may have arisen due to its propensity for increased energy conservation during times of famine [34] . Reasons to explain the emergence of the APOE2 variant may be related to increased cognitive fitness and the "grandmother" effect described as a generational transfer of knowledge [33] . Our understanding of APOE2 selective pressures is limited however, due to the low allele frequency (<2%) and thus insufficient numbers of carriers for population based studies.
APOE3 carriers likely develop AD for entirely different reasons than APOE4 carriers, but they may share a common trigger (i.e. the Western diet). A Western diet (WD) is defined by its constituents such as, man-made ingredients (e.g. trans fatty acids, synthetic additives) unhealthy fat ratios (e.g. high saturated fat and high ratios of n-6 linoleic acid (LA) to n-3 linolenic acid (LNA)), low micronutrient intake (e.g. vitamins, anti-oxidants), high ratio of simple sugars to complex carbohydrates and notably easy access to calorie dense foods [35] . In contrast, our ancestors lived with a limited supply of calorie dense foods which would have put selective pressure on "thrifty" genes like APOE3 [36] . Multiple studies show that APOE3 J o u r n a l P r e -p r o o f carriers (human or mouse) store energy more efficiently than APOE4 carriers, which would be detrimental in times of caloric excess, yet beneficial in times of famine. As humans transitioned to a more population dense agricultural society, access to high quality nutrient dense food was consumed primarily by the ruling class which would increase the selective pressure on thrifty genes like APOE3 in the general population (i.e. subservient class), slowly eroding the APOE4 allele frequency [36] . This dichotomy in food consumption habits would persist until the early 20 th century (coinciding with an increase in lifespan) to present day where access to low quality calorie dense food is attainable by nearly everyone ad libitum. This perfect storm of increased lifespan, bountiful calories, reduced physical activity, chronic stress, etc. may explain why over one third of sporadic AD occurs in APOE3 carriers.
On the other hand, the reasons why APOE4 carriers are at an increased risk for AD could be due to an entirely different etiology which has its roots in inflammation. Again, considering that infectious disease was the number one cause of death until the early 20 th century, infections would have maintained strong selective pressure on the APOE4 allele to the levels seen today from the United States (14% allele frequency) to central Africa (40%) [37] .
Prior to the evolution of the APOE gene, our non-human primate ancestors contained an APOE4-like allele which would have worked well to extract cholesterol and fat from a predominantly vegetarian diet [38] that consisted primarily of plants, fruits, large seeds and underground vegetables [39] . As our ancestors transitioned from being predominantly herbivores to omnivores they would have been exposed to new parasites and pathogens in meat [40] that may have elicited additional selective pressures on the APOE gene. Again, multiple studies show that apoE4 expression results in a stronger immune/inflammatory response than apoE3 or E2 which would be considered advantageous for combating infectious diseases during the pre-reproductive phase of life [30] . However, too strong of an immune response in the post-reproductive years (e.g. chronic inflammation in cardiovascular disease) J o u r n a l P r e -p r o o f could be deleterious which classifies APOE4 as an antagonistic pleiotropic gene [29] . This is based on the idea that prolonged consumption of a high cholesterol and saturated fat diet leads to chronic low grade inflammation and increased atherosclerosis which is more prevalent in APOE4 carriers. Hypothetically, apoE4's effect on lowering LDLR levels [14] could also reduce cellular uptake of beneficial lipids like docosahexaenoic acid (DHA) that would be packaged with cholesterol in the same lipoprotein particle. This is important because essential fatty acids LNA and LA are derived solely from diet and therefore must be taken up by fatty acid binding proteins (transporters) in the brain which is regulated by intracellular cholesterol levels [41] [42] .
It's also important to note that excess LA's are considered pro-inflammatory [43] whereas LNA's are anti-inflammatory [44] and that the highest concentration of DHA in the body is found at the neuronal synapse [45] [46] . A predominantly vegetarian diet would contain a very low cholesterol to LA to LNA ratio (approximately 1:1:1) [35] . This ratio would be considered healthy and sufficient to supply the brain with adequate levels of DHA even in APOE4 carriers [47] . In contrast, the WD has a high ratio of cholesterol to LA to LNA ratio (approximately 10:40:1) [35] [43] which would result in significantly reduced uptake of LNA derivatives like DHA. Note that the high LA: LNA (40:1) ratio in WD's is based on three factors; low consumption of LNA and its derivatives (e.g. DHA), the fact that LA out competes LNA for desaturase enzymes (required for conversion of LNA to long chain polyunsaturated fatty acids (PUFA's)) and the fact that the WD contains low levels of anti-oxidants required to protect PUFA's from oxidation which would be especially damaging to DHA with six double bonds. Thus, APOE4 carriers on a WD (10:40:1 lipid ratio coupled with low anti-oxidant protection) would deliver low to insufficient levels of DHA to the brain, leaving neurons vulnerable to age dependent insults while concomitantly oversupplying pro-inflammatory LA fatty acids to the brain.
J o u r n a l P r e -p r o o f

Brain lipid metabolism
The contribution of dietary fats to overall brain health is well documented. Essential fatty acids (EFA's) are derived solely from diet where they are converted to long chain PUFA's in the liver and are then transported across the blood brain barrier via passive diffusion or active transport proteins at the blood brain barrier [48] . The brain and specifically synaptic membranes contain the highest concentration of DHA in the body [49] [46] . Aside from the known uptake of EFA from dietary sources, other dietary fatty acids have been shown to alter the phospholipid composition in neuronal cell membranes [50] [51] [52] . Several studies have measured reduced levels of specific lipid species (e.g. DHA, ceramides, sulfatides and ganglioside GM1) in the brains of AD patients [53] [54] [55] and suggest that changes in these lipids may be more important than cholesterol levels. Three groups used LC-MS/MS to measure the lipid composition in apoE (-/-), wild type and transgenic GFAP apoE3 mice and found significant differences in the levels of sulfatides [55] , DHA in synaptosomes [56] and the fatty acid composition in phospholipids [57] . Recently Sharman et al. concluded that no gross differences in brain phospholipids could be found in the apoE targeted replacement (TR) mice concluding that there is no apoE isoform specific effect on brain lipid species in the absence of an environmental (e.g. dietary) challenge [58] . However, other groups found significant reductions in sulfatide levels in apoE4 TR mice compared to apoE3 [55] [59] in animals fed a normal diet.
Sulfatides are a class of sulfoglycolipids which structurally makes up one fifth of the galactolipids in the myelin sheath, but also have been implicated in synaptic plasticity [60] and reduced levels have been found in AD vs controls [61] . Overall, more extensive lipid analysis needs to be done in better animal models of sporadic AD, challenged with a WD.
ApoE may regulate synaptic integrity through transport, uptake and redistribution of cholesterol and phospholipids in neuronal membranes [62] [63] . Although neurons are capable of synthesizing cholesterol, the formation of mature synapses (plasticity) depends on glial-J o u r n a l P r e -p r o o f derived cholesterol which is delivered by apoE-containing high density lipoprotein (HDL) like particles [64] . In fact, astrocytes and oligodendroglia synthesize the majority of cholesterol in the brain [65] [66] . The significance of sufficient amounts of cholesterol and phospholipids is highlighted in the work by Hering et al. [67] who show that the depletion of cholesterol and sphingolipids leads to a loss of synapses and spine numbers in primary hippocampal neurons.
Barres et al. [68] demonstrated that retinal ganglion cells exhibited a 70-fold increase in synaptic transmission when co-cultured with astrocytes, and concluded that apoE-containing HDL particles were responsible for this increase. Cholesterol and phospholipids are required not only for neuronal cell viability [69] but for synaptic plasticity as well. We suggest that apoE4 does not provide the necessary lipids for extensive synaptic plasticity when chronically exposed to a diet consisting of high cholesterol, high saturated-LA fat and low LNA fatty acids (i.e. a Western diet) compared to apoE3.
Epidemiology
The prevalence of AD is significantly higher in Westernized countries due to increased life span, co-morbidities and negative lifestyle factors such as poor diets and low physical activity [70] . As developing countries become more Westernized the incidence of AD increases.
Studies show that as people migrate from developing to developed countries and become assimilated into the new culture the incidence of AD increases [71] [72] . Understandably many lifestyle factors change with exposure to a new culture however, there are strong arguments to suggest that Westernized diet consumption is a significant contributing factor. Hendrie et al. Epidemiological studies demonstrate that several components of Westernized diets , such as; high cholesterol [74] low micronutrient intake (folate, thiamine, choline, vitamin E, C, B6, antioxidants) [75] [76] , high levels of saturated and trans-fats [77] and low levels of n-3 fatty acids may contribute to increased risk of AD [77, 78] [79] [80] . Several other studies show that an imbalance in lipid metabolism during midlife may be the strongest indication for risk of dementia [81] [82] [83] . This imbalance in lipids or "lipid dyshomeostasis" is the result of poor dietary habits exemplified in Western lifestyles [71] . The link between APOE genotype, WD and risk of cardiovascular disease had been known long before the investigations of a relationship between APOE, WD and AD began. The statin trials in the early 2000's highlighted cholesterol as a significant risk factor in AD [84] [85] prompting researchers to look at the possibility that APOE and cholesterol levels may influence risk of AD. Although the data to support APOE regulation of peripheral cholesterol in AD has diminished, it doesn't dismiss the fact that Western style diets are still considered a significant risk factor in AD.
Studies looking at the association between WD and AD are confounded by the fact that it's difficult to interpret what people truly eat as they are notorious for misreporting the foods they consume and factors such as shelf life, source of foods and incomplete lists of ingredients (especially in processed foods) further confuse the study outcomes. Too much emphasis has been placed on singular ingredients as culprits in disease and testing of singular nutrients in clinical trials have exhibited very little efficacy. These research studies (or clinical trials) that focus on a single dietary ingredient do not take into account the complexity inherent within any diet and the synergistic nature of ingredients that can produce varying outcomes over long periods of time. With the exception of deficiencies in essential fats or vitamins, no single ingredient is responsible for producing complex diseases like AD. The Western diet is a J o u r n a l P r e -p r o o f complex mixture of fats, carbohydrates and proteins plus synthetic additives that needs to be studied in total and whose injurious effects typically overcome the resiliency of youth only to manifest later in life.
Chronic consumption of Westernized diets also result in co-morbidities such as obesity, diabetes, hypertension and heart disease [86] . Obesity, particularly in midlife, is associated with increased risk for mild cognitive impairment and AD [87] [83] . Obese APOE4 carriers have elevated levels of plasma cholesterol levels, circulating triglycerides, and insulin resistance [88] even though APOE4 carriers have a lower average body mass index than APOE3 carriers (E3 > E4) [89] . APOE4 carriers are also at increased risk for cardiovascular disease and development of metabolic syndrome [90] [91] . It still remains to be determined to what extent the duration of WD exposure and the timing of WD exposure contributes to increased risk of AD. It's very possible that exposure to a WD in aged individuals (when repair and regenerative mechanisms are declining) imparts greater risk than exposure during youth or midlife.
Animal studies: Diet, APOE and AD
Multiple animal studies have reported a positive relationship between high fat/high cholesterol diets and various biomarkers of AD such as AB levels, gliosis and impaired energy metabolism [92] [93] . This review focuses only on studies involving human APOE, diet and AD.
Many factors can influence the results in these studies such as; the type of diet used, length and timing of exposure and the animal model used, making it very difficult to compare studies and draw firm conclusions. For example, Lim et al. tested the effects of a high fat, high cholesterol (HC) diet (10% fat, 0.75% cholesterol, 0.3% cholate) in apoE TR mice beginning at 6 weeks for a period of 13 or 39 weeks, then performed lipidomic analysis on whole brain tissue [94] . As expected there was no change in brain cholesterol levels between the HC vs control diet (i.e. the brain synthesizes its own cholesterol) however cholesterol esters were significantly higher in animals fed the (HC) diet and the apoE4 mice had higher levels than E3 mice. It's difficult to J o u r n a l P r e -p r o o f extrapolate these findings to AD risk in humans considering the HC diet shares very little similarities to a Western diet, the exposure time was limited to young animals (who actually lost weight compared to control animals) and a synthetic bile acid (cholate) was added which is known to cause chronic inflammation [95] potentially confounding the results. Another study in apoE TR mice exposed to a more Western style diet (designed by manufacture Harlan Teklad #88137) showed a stronger correlation to human population studies such that apoE3 TR mice gained more weight than apoE4 mice and the apoE4 mice exhibited worse metabolic outcomes such as higher fasting blood glucose and insulin levels [96] [97] . In yet another study using a slightly different Western diet (Research diet (RD) #D12451B) resulted in the expected weight gain difference (E3>E4) and also showed greater deficits in spatial memory and novel object recognition in apoE4 compared to apoE3 TR mice [98] . There are no HFD studies in apoE2 TR mice likely due to the reduced interest in APOE2 and AD along with the fact that the apoE2 homozygous mice develop type III hypolipoproteinemia which complicates the interpretation of results [99] . All the aforementioned studies examined the interaction between WD and APOE in the absence of amyloid pathology (i.e. used a non-AD model) which provides some insight into the effects of diet and peripheral metabolism on brain function.
Unfortunately, the only mice available to the scientific community for studying the effects of WD, APOE and amyloid pathology are transgenic mice that overexpress mutant human amyloid precursor protein (APP) and mutant presenilin (PS) crossed to the apoE TR mice. The main caveats with these mice are; the mutant transgenes are overexpressed by an artificial promoter cutting off any potential biofeedback that a WD might influence, transgene expression is temporally and spatially incorrect, and transgene expression results in massive amyloidosis in young animals irrespective of age (i.e. which is critical for diet induced disease in humans). The EFAD mice represent a cross between the apoE TR mice and 5 familial AD mutations which is the most aggressive animal model of amyloidosis available and has been used by several groups to study the effects of WD, APOE and AD. In one such case, E3FAD and E4FAD male mice at 3 months were fed a WD (RD #12451) for 12 weeks resulting in significant weight gain in the E3FAD mice over normal diet controls, and only slightly higher weight gains in E4FAD over controls [102] . Only the WD fed E4FAD mice showed increases in amyloid burden and markers of gliosis with no reported measures of neurodegeneration [102] .
When female EFAD mice on the same WD (RD#12451) were examined only the E3FAD mice exhibited WD induced increases in amyloid burden highlighting the importance of sex in animal model studies [103] . Another study using a less aggressive animal model of amyloidosis (i.e. APP/PS1(exon 9 deletion)/APOE TR) in both male and female 3 month old mice were fed a high fat diet (RD#12079B) for 12 weeks, then analyzed for changes in their amyloid burden and transcriptome [104] . The high fat diet exposure increased amyloid burden in the APP/PS1/E4 mice only and transcriptome analysis revealed different gene network activity between the sexes [104] . It remains difficult to interpret gene by environment interactions when using transgenic animals. To better understand these types of interactions human knock in models with intact biofeedback loops should be used as it's highly probable that WD exposure would be expected to influence multiple genetic pathways. In our own studies using transgenic J o u r n a l P r e -p r o o f Journal Pre-proof APP/PS1/APOE TR on WD we found that in the absence of age (>18 month old) we were unable to recapitulate the full phenotype of AD which includes AB deposition, tau pathology, robust gliosis and most importantly significant neurodegeneration.
Conclusion
Although evidence supporting the link between Westernized diets and increased risk of AD continues to grow, questions remain regarding APOE's role in this relationship. The ambiguity of APOE's role is perhaps a result of using inaccurate animal models of sporadic AD, evolving definitions of what constitutes a healthy diet, unreliable dietary information in study cohorts and a lack of APOE genotyping in human population based studies. One of the most challenging questions we face concerning diet's role in disease is the length and timing of WD exposure. For example, is it important that WD exposure encompasses the full length of one's life or could it simply be that this exposure only need occur during life's most vulnerable time period (i.e. when age related repair/regeneration and immune mechanisms are impaired (e.g. >60 years old))? It will take extraordinary patience and revenue to test these parameters in both human and animal studies. The fact that age is the most significant risk factor in AD is incontrovertible, yet we continue to test the effects of other risk factors (i.e. diet and APOE) in young animal models potentially losing years of effort in identifying true targets of disease etiology and progression. A paradigm shift needs to occur in the minds of funding agencies demanding that studies into diseases of aging employ age in the experimental design.
It is also important to keep in mind that AD is finally being recognized as a spectrum of endophenotypes in which WD, APOE and age may constitute just one of these endophenotypes. The number of potential endophenotypes rises considering that WD and age are recognized as significant risk factors for multiple co-morbid conditions, including but not J o u r n a l P r e -p r o o f limited to hypertension, type II diabetes, and heart disease. This means WD, APOE genotype and AD which represent just one endophenotype of sporadic AD could be further sub-divided into unique etiologies that may or may not share common mechanisms of action.
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